Jin JD - Search Results

1

The Antithrombotic Effect of Recombinant Neorudin on Thrombi.

Liu YB, Zhang L, Zhou XC, Zhou Y, Liu Y, Zheng C, Xu X, Geng PP, Hao CH, Zhao ZY, Wu CT, Jin JD. Liu YB, et al. Among authors: jin jd. Drug Des Devel Ther. 2022 Jun 2;16:1667-1678. doi: 10.2147/DDDT.S353088. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 35677424 Free PMC article.

2

Locally activity-released bifunctional fusion protein enhances antithrombosis and alleviates bleeding risk.

Shi B, Yu A, Liu Y, Li J, Jin J, Dong C, Wu C. Shi B, et al. J Thromb Thrombolysis. 2007 Dec;24(3):283-92. doi: 10.1007/s11239-007-0036-6. Epub 2007 May 9. J Thromb Thrombolysis. 2007. PMID: 17487572

3

[Research progress in hirudin fusion protein--review].

Zhang CL, Yu AP, Jin JD, Wu CT. Zhang CL, et al. Among authors: jin jd. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Feb;15(1):215-8. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007. PMID: 17490558 Review. Chinese.

4

Adipose-derived stem cells cooperate with fractional carbon dioxide laser in antagonizing photoaging: a potential role of Wnt and β-catenin signaling.

Xu X, Wang HY, Zhang Y, Liu Y, Li YQ, Tao K, Wu CT, Jin JD, Liu XY. Xu X, et al. Among authors: jin jd. Cell Biosci. 2014 May 2;4:24. doi: 10.1186/2045-3701-4-24. eCollection 2014. Cell Biosci. 2014. PMID: 24917925 Free PMC article.

5

Effect of serum choice on replicative senescence in mesenchymal stromal cells.

Liu Y, Li YQ, Wang HY, Li YJ, Liu GY, Xu X, Wu XB, Jing YG, Yao Y, Wu CT, Jin JD. Liu Y, et al. Among authors: jin jd. Cytotherapy. 2015 Jul;17(7):874-84. doi: 10.1016/j.jcyt.2015.02.012. Epub 2015 Mar 19. Cytotherapy. 2015. PMID: 25800776

6

Development, validation, and clinical pharmacokinetic application of ultra-performance liquid chromatography/tandem mass spectrometry method for simultaneously determining a novel recombinant hirudin derivative (Neorudin) and its active metabolite in human serum.

Dong X, Meng Z, Jin J, Gu R, Dou G. Dong X, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Sep 15;1063:204-213. doi: 10.1016/j.jchromb.2017.08.030. Epub 2017 Aug 24. J Chromatogr B Analyt Technol Biomed Life Sci. 2017. PMID: 28886579 Clinical Trial.

7

Evaluating prodrug characteristics of a novel anticoagulant fusion protein neorudin, a prodrug targeting release of hirudin variant 2-Lys47 at the thrombosis site, by means of in vitro pharmacokinetics.

Dong X, Gu R, Zhu X, Gan H, Liu J, Jin J, Meng Z, Dou G. Dong X, et al. Eur J Pharm Sci. 2018 Aug 30;121:166-177. doi: 10.1016/j.ejps.2018.05.025. Epub 2018 May 23. Eur J Pharm Sci. 2018. PMID: 29802897

8

A Sandwich Structure of Human Dental Pulp Stem Cell Sheet, Treated Dentin Matrix, and Matrigel for Tooth Root Regeneration.

Meng H, Hu L, Zhou Y, Ge Z, Wang H, Wu CT, Jin J. Meng H, et al. Stem Cells Dev. 2020 Apr 15;29(8):521-532. doi: 10.1089/scd.2019.0162. Stem Cells Dev. 2020. PMID: 32089088

9

Predicting the metabolic characteristics of neorudin, a novel anticoagulant fusion protein, in patients with deep vein thrombosis.

Dong X, Meng Z, Gu R, Zhu X, Gan H, Jin J, Liu J, Dou G. Dong X, et al. Thromb Res. 2020 Oct;194:121-134. doi: 10.1016/j.thromres.2020.05.048. Epub 2020 Jun 1. Thromb Res. 2020. PMID: 32788104

10

A phase I, single and continuous dose administration study on the safety, tolerability, and pharmacokinetics of neorudin, a novel recombinant anticoagulant protein, in healthy subjects.

Liu Y, Wang M, Dong X, He J, Zhang L, Zhou Y, Xia X, Dou G, Wu CT, Jin J. Liu Y, et al. Pharmacol Res Perspect. 2021 May;9(3):e00785. doi: 10.1002/prp2.785. Pharmacol Res Perspect. 2021. PMID: 33957018 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page